MWOK:XETRA:XETRA-Amundi MSCI USA ESG Leaders Extra UCITS ETF DR - USD (USD)

ETF | Others |

Last Closing

USD 15.264

Change

+0.08 (+0.54)%

Market Cap

USD 0.90B

Volume

233.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-16 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XM1D:XETRA Xtrackers MSCI Japan UCITS ETF..

+0.26 (+0.51%)

USD 448.39B
LCUJ:XETRA Lyxor Core MSCI Japan (DR) UCI..

+0.11 (+0.71%)

USD 191.96B
PRAJ:XETRA Amundi Index Solutions - Amund..

+0.23 (+0.87%)

USD 177.46B
PR1J:XETRA Amundi Prime Japan UCITS ETF D..

+0.20 (+0.72%)

USD 177.46B
XDJP:XETRA Xtrackers Nikkei 225 UCITS ETF..

+0.02 (+0.06%)

USD 157.79B
TM5:XETRA T-MOBILE US INC.DL-00001

+0.46 (+0.29%)

USD 126.93B
JARI:XETRA Amundi Index Solutions - Amund..

+0.28 (+0.65%)

USD 105.55B
8R80:XETRA Amundi Index Solutions - Amund..

+1.40 (+0.99%)

USD 105.05B
UIM5:XETRA UBS (Lux) Fund Solutions - MSC..

+0.34 (+0.68%)

USD 85.64B
SXR8:XETRA iShares Core S&P 500 UCITS ETF..

-3.92 (-0.77%)

USD 80.38B

ETFs Containing MWOK:XETRA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 11.94% 76% C+ 75% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 11.94% 76% C+ 74% C
Trailing 12 Months  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) N/A N/A N/A N/A N/A
Risk Adjusted Return N/A N/A N/A N/A N/A
Market Capitalization 0.90B 77% C+ 69% C-

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

What to not like:

There is nothing we particularly dislike